We are live on ! Find out more
AHCO icon

AdaptHealth

182 hedge funds and large institutions have $1.32B invested in AdaptHealth in 2023 Q2 according to their latest regulatory filings, with 40 funds opening new positions, 63 increasing their positions, 54 reducing their positions, and 30 closing their positions.

New
Increased
Maintained
Reduced
Closed

509% more call options, than puts

Call options by funds: $12.7M | Put options by funds: $2.09M

33% more funds holding in top 10

Funds holding in top 10: 34 (+1)

33% more first-time investments, than exits

New positions opened: 40 | Existing positions closed: 30

17% more repeat investments, than reductions

Existing positions increased: 63 | Existing positions reduced: 54

6% more funds holding

Funds holding: 172182 (+10)

5% less capital invested

Capital invested by funds: $1.38B → $1.32B (-$64.1M)

1.44% less ownership

Funds ownership: 82.17%80.73% (-1.4%)

Holders
182
Holders Change
+10
Holders Change %
+5.81%
% of All Funds
2.86%
Holding in Top 10
4
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+33.33%
% of All Funds
0.06%
New
40
Increased
63
Reduced
54
Closed
30
Calls
$12.7M
Puts
$2.09M
Net Calls
+$10.6M
Net Calls Change
-$4.61M
Name Holding Trade Value Shares
Change
Change in
Stake
LCP
26
LGT Capital Partners
Switzerland
$6.78M
Norges Bank
27
Norges Bank
Norway
$6.6M +$1.47M +132,000 +32%
CIP
28
Chartwell Investment Partners
Pennsylvania
$5.9M -$143K -12,849 -3%
SI
29
Sapience Investments
California
$5.58M +$938K +84,180 +22%
Principal Financial Group
30
Principal Financial Group
Iowa
$5.54M -$87.6K -7,861 -2%
Citadel Advisors
31
Citadel Advisors
Florida
$5.53M -$7.39M -663,488 -59%
GLA
32
Great Lakes Advisors
Illinois
$5.2M -$2.12M -190,304 -31%
New York State Common Retirement Fund
33
New York State Common Retirement Fund
New York
$5.18M +$174K +15,657 +4%
Morgan Stanley
34
Morgan Stanley
New York
$5.18M -$1.66M -149,278 -26%
Ameriprise
35
Ameriprise
Minnesota
$5.15M -$9.9M -888,248 -68%
Dimensional Fund Advisors
36
Dimensional Fund Advisors
Texas
$4.92M +$4.51M +404,240 New
EST
37
EA Series Trust
Pennsylvania
$4.73M +$4.33M +388,669 New
EF
38
Empowered Funds
Pennsylvania
$4.73M +$4.33M +388,669 New
Bank of America
39
Bank of America
North Carolina
$4.57M -$14.8M -1,329,467 -78%
Janus Henderson Group
40
Janus Henderson Group
United Kingdom
$4.38M +$1.01M +90,628 +34%
Goldman Sachs
41
Goldman Sachs
New York
$3.68M +$185K +16,614 +6%
Prudential Financial
42
Prudential Financial
New Jersey
$3.59M +$959K +86,019 +41%
AA
43
AlphaCentric Advisors
Puerto Rico
$3.44M +$1.85M +166,000 +142%
AQR Capital Management
44
AQR Capital Management
Connecticut
$3.29M +$1.93M +173,274 +178%
Sumitomo Mitsui Trust Group
45
Sumitomo Mitsui Trust Group
Japan
$3.24M -$33.7M -3,020,278 -92%
RhumbLine Advisers
46
RhumbLine Advisers
Massachusetts
$2.67M -$134K -11,986 -5%
Susquehanna International Group
47
Susquehanna International Group
Pennsylvania
$2.66M +$1.08M +97,110 +80%
First Eagle Investment Management
48
First Eagle Investment Management
New York
$2.65M +$1.34M +120,530 +124%
Legal & General Group
49
Legal & General Group
United Kingdom
$2.53M -$34.4K -3,088 -1%
N
50
Nuveen
North Carolina
$2.52M -$768K -68,914 -25%

AHCO Hedge Fund Activity: Q2 2023 in Review

182 of the 6,369 institutional investors tracked by Wall St. Rank reported a position in AdaptHealth (AHCO) for Q2 2023, worth a combined $1.32B — down 4.6% from $1.38B a quarter earlier.

Buyers outnumbered sellers: 40 funds opened new AHCO positions and 30 closed out — a net gain of 10 holders — while 63 added to existing stakes and 54 trimmed.

The largest buyer was Reinhart Partners, adding an estimated $23.8M. The largest seller was Sumitomo Mitsui Trust Group, cutting an estimated $33.7M.

  • 182 institutional investors held AdaptHealth (AHCO) as of Q2 2023, up from 172 in Q1 2023.
  • Funds reported $1.32B of AdaptHealth stock for Q2 2023, down 4.6% quarter-over-quarter.
  • 40 funds opened new AdaptHealth positions in Q2 2023 and 30 closed out, a net change of +10 holders.
  • The largest AdaptHealth buyer in Q2 2023 was Reinhart Partners, an estimated $23.8M added.
  • The largest AdaptHealth seller in Q2 2023 was Sumitomo Mitsui Trust Group, an estimated $33.7M sold.

Based on aggregated 13F filings for Q2 2023.